Reducing Skin Tone Inequities in Chronic Venous Insufficiency
NCT ID: NCT06798766
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
51 participants
OBSERVATIONAL
2025-06-01
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To achieve this there will be two parts to this study.
1. We will explore patient journeys and patient experiences of people with dark skin tones diagnosed with chronic venous insufficiency. From this we will learn from people with dark skin tones about how they recognised skin changes in their lower legs to further inform clinical assessment guidance and techniques. We will also listen to their patient journey to identify what areas worked well and what could be developed. This will help us plan how care could be improved for similar people.
2. We will record how skin changes look and feel in people with dark skin tones and known venous disease, and photograph this. We will consider whether some additional techniques used in practice to look and feel the skin is useful and whether changing the colour balance and manipulating the photographs is useful to see these skin changes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EdemaWear to Reduce Edema in Hospitalized Patients With CVI:
NCT03904602
Volume Estimation of the Limb After VEnous Treatment
NCT03703765
Venous Compression in Fontan
NCT07220226
Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life
NCT02050061
The Effects of Compression Stockings on Pressure Parameters in Patients With Chronic Venous Insufficiency
NCT01558024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this work package is to:
• Explore patient journeys and patient experiences of people with dark skin tones diagnosed with chronic venous insufficiency.
1.2 Purpose Patient journeys will be used as a catalyst for change in the identification of CVI for people with dark skin tones. We also aim to learn from people with dark skin tones about how they recognised skin changes in their lower legs to further inform clinical assessment guidance and techniques.
1.3 Study design This part of the study is a qualitative interview study. This design ensures patients experience from their perspectives are captured.
Mapping the clinical journey from the patient perspective has significant potential to inform the redesign of new, patient centred models of care and service delivery and understanding delays in diagnosis. The areas identified within the interviews will enable future interventions to target failures in current clinical care and the narratives of patient experiences captured within the interviews will also be recorded to form the basis of trigger films or quotes that can be used within the co-design process of future interventions using a experience-based co-design approach.
Participants will also explain how they noticed skin changes in their own skin, to aid in the development of appropriate language and explanations of skin changes in this patient group in an appropriate way.
To achieve the objective each consenting participant will
1. Participate in a semi-structured interview (approx. 1hour) exploring patient experience and patient journey.
2. Self-report their skin tone using Ho and Robinson's skin tones chart, their ethnicity, age \& gender.
1.4 Participants 1.4.1 Source of participants.
Participants will be recruited from any of the following :
* through charity organisations such as the "Lyndsey Leg Club Foundation". Publicity for recruitment will be available by adverts circulated through their members lists, on social media or as in person posters at events.
* people who have previously expressed interest in being involved in research on leg ulcers/ venous insufficiency who have a dark skin tone.
* through the "Be Part of Research" network.
* Clinical settings (hospital and community settings).
* Social media adverts 1.4.2 Inclusion / Exclusion Criteria inclusion criteria
* people with chronic venous insufficiency, or their close family member
* the person with chronic venous insufficiency has a dark skin tone (from Ho and Robinson skin tone range 2b-6b).
* ability to give informed consent exclusion criteria
* person with chronic venous insufficiency has a light skin tone (from Ho and Robinson skin tone range 1a-2a, ).
* people unable to speak and understand English
* people unable to give informed consent.
Work package 2 - Informing skin assessment technique and medical photography 2.1 Objective
The primary objective of this work package is to:
• Investigate the efficacy, inter-rater reliability and patient experience of skin assessment techniques in the assessment of skin changes associated with chronic venous disease in people with dark skin tones.
The secondary objective is to:
• determine the acceptability of undergoing these assessments from patient and nurse perspective 2.2 Purpose To explore whether non-invasive assessment (inspection, palpation and skin photography) techniques are appropriate to assess skin changes associated with venous hypertension and chronic venous insufficiency in people with dark skin tones. It will do this by providing proof-of-concept of the use of non-invasive inspection and palpation techniques currently used in practice and techniques recommended by clinical experts. We hope this will improve the evidence base of these techniques. It will also provide proof of concept whether skin photography techniques can be modified to improve skin changes associated with venous hypertension and chronic venous disease on people with dark skin tones. This following suggestions in previous research on skin assessment in people with dark skin tones that modifying the photographs is advantageous to assess for erythema associated with pressure damage in the laboratory setting. However, to date no research has considered whether this could be advantageous to assist in the detection of skin changes associated with CVI, or could be undertaken in the clinical setting.
2.3 Study design This part of the study is an analytical cross-sectional study of 15 patients which includes reviewing participating patients clinical notes. This design enables assessment information to be captured on participating individuals and analyse associations with assessment data from scan results to enable proof-of-concept of skin assessment techniques in people with dark skin tones.
To achieve this objective each consenting participant will
1. undergo the following:
* a physical assessment of their lower legs using inspection and palpation to determine both their clinical (C) classification of the CEAP and their Venous Clinical Severity Score.
* answer questions relating to their leg including whether they have noticed any visual skin changes or any changes in symptoms such as pain, itching or sensation
* wound care photography under standard and enhanced photography techniques in the medical photography studio This data will be compared to their observations taken as part as their clinical care (such as Duplex Scan results, Consultant Diagnosis, ABPI results, CEAP and Venous Clinical Severity Scores reported by the clinical team).
2. Self-report their skin tone using Ho and Robinson's skin tones chart, their ethnicity, age \& gender.
3. Give their feedback during a qualitative interview of their experiences of undergoing these clinical assessments based on relevant dimensions of acceptability identified by Sekhon and colleagues (affective attitude, burden, ethicality, perceived effectiveness), and report any adverse events they experienced when undertaking these additional assessments.
The research nurse will also give their feedback of undertaking the assessments on each patient in their structured field notes documenting relevant dimensions of acceptability identified by Sekhon and colleagues (affective attitude, perceived effectiveness, self-efficacy).
2.4 Participants 2.4.1 Source of participants. Participants will be recruited from a clinical setting 2.4.2 Inclusion / Exclusion Criteria inclusion criteria
* people diagnosed with chronic venous insufficiency at NHS trust
* people with a dark skin tones (from Ho and Robinson skin tone range 2b-6b).
* ability to give informed consent
* either coming back to the hospital for surgery or being able to travel back to the hospital to undergo physical assessment and skin photography prior to any intervention.
* have duplex scan results to show blood flow in their leg(s) exclusion criteria
* person with chronic venous insufficiency has a light skin tones (from Ho and Robinson skin tone range 1a-2a).
* people unable to speak and understand English
* people unable to give informed consent.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Work-package 1 - Mapping patient journeys and patient experiences
Participating in semi-structured interview exploring patient experience and patient journey of people with dark skin tones living with chronic venous insufficiency in the U.K.
Number of people: 36
No interventions assigned to this group
Work package 2 - Informing skin assessment technique and medical photography
People with dark skin tones and known chronic venous insufficiency with up to date scan results of their blood flow seen by our trust partner (the hub of the southeast Thames vascular network) by either acute or community services.
Number of people: 15
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the person with chronic venous insufficiency has a dark skin tone (from Ho and Robinson skin tone range 2b-6b, table 1).
* people diagnosed with chronic venous insufficiency at NHS trust
* people with a dark skin tones (from Ho and Robinson skin tone range 2b-6b, table 1).
* ability to give informed consent
* either coming back to the hospital for surgery or being able to travel back to the hospital to undergo physical assessment and skin photography prior to any intervention.
Exclusion Criteria
* people unable to speak and understand English
* people unable to give informed consent.
* person with chronic venous insufficiency has a light skin tones (from Ho and Robinson skin tone range 1a-2a, table 1).
* people unable to speak and understand English
* people unable to give informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guy's and St Thomas' NHS Foundation Trust
OTHER
University of Surrey
OTHER
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Victoria J Clemett, PhD, BNurs
Role: PRINCIPAL_INVESTIGATOR
King' College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guy's and St Thomas' NHS Foundation Trust
London, London, United Kingdom
King's College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS Number 350871
Identifier Type: OTHER
Identifier Source: secondary_id
EDGE reference 175656
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.